Xponance’s AdaptHealth AHCO Stock Holding History

Xponance’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,124	Closed	-$96.4K	–	1448
2024 Q4	$96.4K	Sell	10,124 -844	-8%	-$8.54K	﹤0.01%	1368
2024 Q3	$123K	Buy	+10,968	New	+$117K	﹤0.01%	1298

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Xponance's AHCO Position: Q1 2025 in Review

Xponance sold out of AdaptHealth (AHCO) in Q1 2025, closing a stake of 10,124 shares — an estimated $96.4K sold.

Xponance first reported a position in AHCO in Q3 2024 and held it in 2 quarters. The position peaked at $123K in Q3 2024. 226 funds tracked by Wall St. Rank hold AHCO as of Q1 2025.

Xponance reported no remaining AdaptHealth position as of Q1 2025 after selling out during the quarter.
Xponance sold 10,124 AdaptHealth shares in Q1 2025, an estimated $96.4K.
Xponance first reported a position in AdaptHealth in Q3 2024 and held it in 2 quarters.
Xponance's AdaptHealth position peaked at $123K in Q3 2024.
226 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2025.

Based on Xponance's 13F filing for Q1 2025, filed 1 May 2025.